Stratifai
Berlin, DE · Founded 2023 · 5 known investors
Find your way into Stratifai
780 people in our graph share verified history with the Stratifai team — schools, employers, funds. One of them is your warm intro.
Ryan Isonounlockedknows Jakob Nikolas Kather · together at Credit Suisse (overlapped)
×7knows the team · via Credit Suisse
×2knows the team · via TalTech – Tallinn University of Technology
×2knows the team · via Universidad Politécnica de Madrid
StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights. Its offerings target cancer diagnostics for oncology institutions and pharmaceutical companies, with an initial focus on breast cancer recurrence risk.
Founders & leadership
Stratifai was founded in 2023 by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, and Omar El Nahhas.
DT
Daniel TruhninCo-Founder & Chief Medical Officer
FK
JN
OE
Omar El Nahhasin𝕏CEO & Co-founderComputational-pathology researcher (TU Dresden / Kather lab); CEO of StratifAI.
Investors · 5
Frequently asked questions
- What does Stratifai do?
- StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights. Its offerings target cancer diagnostics for oncology institutions and pharmaceutical companies, with an initial focus on breast cancer recurrence risk.
- Who founded Stratifai?
- Stratifai was founded by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, Omar El Nahhas in 2023.
- Who are Stratifai's investors?
- Stratifai's investors include Debiopharm Innovation Fund, PICUS CAPITAL, Alven, Heliad AG, Neulogy Ventures.
- Where is Stratifai headquartered?
- Stratifai is headquartered in Berlin, DE.